Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05305443 · ClinicalTrials.gov registry record · NA

COVID-19 Treatment Cascade Optimization Study

A NA study of COVID-19, sponsored by University of Illinois at Urbana-Champaign.

Completed
Registry status
NA
Development phase
554
Enrollment target
1
Study location

NCT05305443 is a NA study of COVID-19 that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 554 participants, below the 55,212-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05305443, a NA study of COVID-19, has completed, sponsored by University of Illinois at Urbana-Champaign.

COMPLETED
Registry status
NA
Development phase
554 participants
Enrollment target
1
Study location

Study Summary

This study tests an adaptation of the HIV Continuum of Prevention, Care, and Treatment Framework (CoPCT) for use in tracking COVID-19 testing and follow-up in a medically and socially vulnerable population. This study uses an integrated research collaborative framework that facilitates dialogue among researchers, community members, and service providers as a tool for optimizing the adaptive intervention and will take place at the Comprehensive Behavioral Health Center (CCHC).

Conditions Studied

Interventions

  • BEHAVIORAL Navigation Services
  • BEHAVIORAL Brief Counseling
  • BEHAVIORAL Critical Dialogue
  • BEHAVIORAL Referral and Digital Brochure

Study Locations (1)

Illinois

  • Comprehensive Behavioral Health Center - East Saint Louis

Trial Details

FieldValue
Enrollment Target 554 participants
Start Date 2022-04-04
Est. Completion 2023-08-28
Phase NA

What the Registry Record Tells You About NCT05305443

The ClinicalTrials.gov registry entry for NCT05305443 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 554 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,212-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The listed sponsor is University of Illinois at Urbana-Champaign, which has 129 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 4 interventions - of which Navigation Services is the first listed.

NCT05305443 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05305443 about?

NCT05305443 is a clinical study titled "COVID-19 Treatment Cascade Optimization Study". This study tests an adaptation of the HIV Continuum of Prevention, Care, and Treatment Framework (CoPCT) for use in tracking COVID-19 testing and follow-up in a medically and socially vulnerable population. This study uses an integrated research collaborative framework that facilitates dialogue amon...

What is the current status of trial NCT05305443?

This trial is currently completed. It is a NA study. The enrollment target is 554 participants. The study started on 2022-04-04. Estimated completion is 2023-08-28.

What conditions does trial NCT05305443 study?

This clinical trial studies the following conditions: COVID-19.

What interventions are being tested in trial NCT05305443?

The interventions under investigation include: Navigation Services (BEHAVIORAL), Brief Counseling (BEHAVIORAL), Critical Dialogue (BEHAVIORAL), Referral and Digital Brochure (BEHAVIORAL).

Who is sponsoring clinical trial NCT05305443?

This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05305443 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.